News Gilead Reports the EMA’s MAA and EU-M4all Acceptance of Lenacapavir for Pre-Exposure Prophylaxis (PreP) to Prevent HIV in Individuals at RiskByRidhi RastogiFebruary 25, 20250Comments
News Summit Therapeutics Partners with Pfizer to Assess Ivonescimab in Combination with Pfizer’s ADCs for Various Solid Tumor SettingsByRidhi RastogiFebruary 25, 20250Comments
News Regeneron Presents P-I/II (CHORD) Trial Data of DB-OTO for Profound Genetic Hearing Loss at Association for Research in Otolaryngology 2025ByRidhi RastogiFebruary 25, 20250Comments
News Formycon Reports the MHRA’s Approval of FYB203 (Biosimilar, Eylea) as AhzantiveByRidhi RastogiFebruary 25, 20250Comments
News Sandoz Launches Pyzchiva (Biosimilar, Ustekinumab-ttwe) in the US for Chronic Inflammatory DiseasesByRidhi RastogiFebruary 25, 20250Comments
News Boehringer Ingelheim Introduces Vaxxitek HVT+IBD+H5 Vaccine Against Marek’s Disease, Infectious Bursal Disease and H5 Avian InfluenzaByRidhi RastogiFebruary 25, 20250Comments
News Takeda Reports EMA Approval for Additional SC Administration Option of Takhzyro (lanadelumab) for Patients aged ≥12 with Recurrent HAEByRidhi RastogiFebruary 25, 20250Comments
INSIGHTS+ Disease of the Month – Amyotrophic Lateral Sclerosis (ALS)ByDipanshu DixitFebruary 25, 20250Comments
News Innovent Reports the NMPA’s NDA Acceptance & Priority Review of Neoadjuvant Ipilimumab + Sintilimab for Colon CancerByRidhi RastogiFebruary 24, 20250Comments
